Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

It's a Bear Market, but Is This Stock in Even More Trouble?

TheMotleyFool

0 0

It's a Bear Market, but Is This Stock in Even More Trouble?

This isn't news to anyone, but the market has been struggling all year. Indeed, the S&P 500 is in bear market territory, defined as a 20% (or more) drop from its most recent high. But some stocks are performing even worse.

Take biotech company Novavax (NASDAQ: NVAX). This vaccine maker is down by 64% since the beginning of the year. While the broader market sell-off hasn't helped Novavax, the company has encountered its own issues, too. Should investors give up on Novavax?